Non-coding RNAs modulate pyroptosis in diabetic cardiomyopathy: A comprehensive review

Area of Science:

• Biomedical Science
• Cardiovascular Research
• Molecular Biology

Background:

• Diabetic cardiomyopathy (DCM) is a major cause of heart failure in diabetic patients.
• Pyroptosis, a pro-inflammatory programmed cell death, is implicated in DCM pathogenesis.
• Non-coding RNAs (ncRNAs) play crucial roles in cellular functions and disease progression.

Purpose of the Study:

• To review the regulatory role of ncRNAs in pyroptosis within diabetic cardiomyopathy.
• To explore the mechanisms by which ncRNAs influence pyroptosis and DCM pathophysiology.
• To identify novel therapeutic and diagnostic targets for DCM.

Main Methods:

• Literature review and synthesis of existing research on ncRNAs, pyroptosis, and DCM.
• Analysis of molecular pathways linking ncRNAs to pyroptosis execution in cardiac cells.
• Examination of preclinical and clinical evidence for ncRNA-mediated pyroptosis in DCM.

Main Results:

• ncRNAs are critical regulators of pyroptosis in DCM, influencing its initiation and execution.
• Specific ncRNAs have been identified that modulate key pyroptosis signaling pathways (e.g., inflammasomes).
• Dysregulation of ncRNA-mediated pyroptosis contributes significantly to cardiac dysfunction in DCM.

Conclusions:

• Targeting ncRNA-regulated pyroptosis presents a promising therapeutic strategy for diabetic cardiomyopathy.
• Further research into ncRNA-pyroptosis interactions can lead to novel diagnostic biomarkers for DCM.
• Understanding these molecular mechanisms is key to developing effective treatments for DCM-associated heart failure.